An observational study to evaluate efficacy of romiplostim and eltrombopag in patients with idiopathic thrombocytopenic purpura.
Phase of Trial: Phase IV
Latest Information Update: 12 May 2014
At a glance
- Drugs Eltrombopag (Primary) ; Romiplostim (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 12 May 2014 New trial record